Application Number,Application Type,Active Ingredient,Reference Product Brand Name,Form,Dosage,Reference Product Applicant Name,Approval Date,Reference Product-Marketing Access,RLD,TE Code,Approved ANDA Count,Approved ANDA Details,ANDA Holder-Marketing Access,TA ANDA Count,TA ANDA Details,Discontinued ANDA Count,Discontinued ANDA Details,OB Patent Count,OB Patent Details,OB First Patent Expiry Date,OB Last Patent Expiry Date,OB NCE Status,OB NCE Date,OB Exclusivity Count,OB Exclusivity Details,OB First Exclusivity Expiry Date,OB Last Exclusivity Expiry Date,Orphan Status,REMS Status,DEAS Status,DMF count,DMF Details,Reference Product Label Link,OB Patent Link,extraFlag,Pharma Class793,N,BUTABARBITAL SODIUM,BUTISOL SODIUM,TABLET;ORAL,30MG,MEDA PHARMS,6/5/1939 0:00,"(1)MEDA PHARMS-Meda Pharmaceuticals Inc.,(1)",YES,None,0,None,None,0,None,10,"(1)WHITEWORTH TOWN PLSN,83337;(2)IVAX SUB TEVA PHARMS,84040;(3)SANDOZ,84272;(4)HALSEY,84719;(5)HIKMA PHARMS LLC,85432;(6)BUNDY,85550;(7)WATSON LABS,85772;(8)LANNETT,85866;(9)SANDOZ,85934;(10)TEVA,88631;",0,None,None,None,None,None,0,None,None,None,NO,NO,CIII;,2,"(1)CEDARBURG PHARMACEUTICALS(12/18/1999),(2)CHATTEM CHEMICALS INC(10/04/1999)",http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/000793s025lbl.pdf,http://www.usdinformatics.com/index.php?page=ViewPatent&applno=793&productno=4,F,sdf
